IRBIT is a recently identified protein that modulates the activities of both inositol 1,4,5-triphosphate receptor and pancreas-type Na ؉ /HCO 3 ؊ cotransporter 1, and the multisite phosphorylation of IRBIT is required for achieving this modulatory action. Here, we report the identification of the cleavage and polyadenylation specificity factor (CPSF), which is a multi-protein complex involved in 3 processing of mRNA precursors, as an additional binding partner for IRBIT. We found that IRBIT interacted with CPSF and was recruited to an exogenous polyadenylation signal-containing RNA. The main target for IRBIT in CPSF was Fip1 subunit, and the phosphorylation of the serine-rich region of IRBIT was required both for direct association with Fip1 in vitro and for redistribution of Fip1 into the cytoplasm of intact cells. Furthermore, tert-butylhydroquinone (tBHQ), an agent that induces oxidative stress, increased the phosphorylation level of IRBIT in vivo and in parallel enhanced the interaction between IRBIT and CPSF and promoted the cytoplasmic distribution of endogenous Fip1. In addition to CPSF, IRBIT interacted in vitro with poly(A) polymerase (PAP), which is the enzyme recruited by CPSF to elongate the poly(A) tail, and inhibited PAP activity in a phosphorylation-dependent manner. These findings raise the possibility that IRBIT modulates the polyadenylation state of specific mRNAs, both by controlling the cytoplasmic/nuclear partitioning of Fip1 and by inhibiting PAP activity, in response to a stimulus that alters its phosphorylation state.The inositol 1,4,5-triphosphate (IP 3 ) 3 receptors (IP 3 Rs) are IP 3 -gated Ca 2ϩ channels located on intracellular Ca 2ϩ stores. When the cell is exposed to a stimulus, IP 3 is produced as a second messenger and mediates the release of Ca 2ϩ by interacting with IP 3 Rs. We previously identified an IP 3 R-binding protein termed IRBIT (IP 3 R-binding protein released with inositol 1,4,5-triphosphate) that interacts with the IP 3 -binding core domain of IP 3 R and is dissociated from IP 3 R by physiological concentrations of IP 3 (1). IRBIT binds to IP 3 R through its N-terminal phosphorylated region and suppresses IP 3 R activity at the resting state by blocking IP 3 access to IP 3 R. When cells are exposed to a stimulus resulting in high concentration of IP 3 , IP 3 displaces IRBIT and activates IP 3 R. From these findings, it was speculated that IRBIT regulates Ca 2ϩ release by setting the threshold of IP 3 concentration required for activation of IP 3 R (2). Besides its function in the regulation of IP 3 R activity, IRBIT also binds to and activates pancreas-type Na ϩ /HCO 3 Ϫ cotransporter 1 (pNBC1), indicating a role in the regulation of intracellular and extracellular pH (3). Interestingly, although interactions with IP 3 R and pNBC1 each show unique properties, they also share common features, such the requirement of the N-terminal phosphorylated region (2, 3). The finding that IRBIT binds to and regulates both IP 3 R and pNBC1 suggests that IRBIT is a multifunctional...